Predict your next investment

AJU Pharm company logo
Corporation
HEALTHCARE
ajupharm.co.kr

See what CB Insights has to offer

Investments

1

Partners & Customers

1

About AJU Pharm

AJU Pharm manufactures and sells medicine mainly in ophthalmology and is a total healthcare company that supplies medical devices and health foods in Korea.

AJU Pharm Headquarter Location

600, Gyeongin-ro Guro-gu

Seoul,

South Korea

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

AJU Pharm Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

AJU Pharm Rank

Latest AJU Pharm News

Aju Pharm Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12092018 Prices from USD $250

Sep 29, 2018

Aju Pharm Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250 22:54 EDT 28 Sep 2018 | BioPortfolio Reports Summary Aju Pharm Co Ltd Aju Pharm is a pharma and medical device company. The company operates in the business such as pharmaceutical, CMO , medical device, global business and consumer health business. Its pharmaceutical business provides drugs for hypertension , antibiotics, and antiinflammatory analgesics. Aju Pharm's CMO business division offers oral solids, oral liquids, injectables and cephalosporins. The company's medical device segment offers anchor disposable device, cannula, polyolefin infusion set, adhesive and nonadhesive wound dressings, laparoscopic and thoracoscopic trocars, wire devices and others. It collaborates with medical institutions, medical practitioners, and the academia. The company operates its offices in Suwon, Gangwon, Jeonju, Daegu, Busan, Yongin, Daejeon, Gwangju, Jeju and Gyeongnam, South Korea. Aju Pharm is headquartered in Seoul, South Korea. Aju Pharm Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

AJU Pharm Investments

1 Investments

AJU Pharm has made 1 investments. Their latest investment was in Autotelic Bio as part of their Series A on January 1, 2020.

CBI Logo

AJU Pharm Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/7/2020

Series A

Autotelic Bio

$5.57M

Yes

1

Date

1/7/2020

Round

Series A

Company

Autotelic Bio

Amount

$5.57M

New?

Yes

Co-Investors

Sources

1

AJU Pharm Partners & Customers

1 Partners and customers

AJU Pharm has 1 strategic partners and customers. AJU Pharm recently partnered with RIBOMIC on March 3, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

3/17/2020

Licensor

RIBOMIC

Japan

RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related Macular Degeneration

TOKYO -- -LRB- -RRB- -- RIBOMIC , a clinical stage pharmaceutical company specializing in aptamer therapeutics -LRB- `` RIBOMIC '' TSE-Mothers : 4591 , President and CEO : Yoshikazu Nakamura , Ph.D. -RRB- today announced that RIBOMIC has signed the license agreement with AJU , LTD. , Korean pharmaceutical company -LRB- `` AJU '' -RRB- , for RBM-007 licensing agreement for the indication of the exudative age-related macular degeneration in the territory of Korea and Southeast Asia -LRB- Singapore , Philippines , Thailand , Vietnam , Indonesia , Malaysia , Cambodia and Myanmar ; hereinafter `` the Territory '' -RRB- .

4

Date

3/17/2020

Type

Licensor

Business Partner

RIBOMIC

Country

Japan

News Snippet

RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related Macular Degeneration

TOKYO -- -LRB- -RRB- -- RIBOMIC , a clinical stage pharmaceutical company specializing in aptamer therapeutics -LRB- `` RIBOMIC '' TSE-Mothers : 4591 , President and CEO : Yoshikazu Nakamura , Ph.D. -RRB- today announced that RIBOMIC has signed the license agreement with AJU , LTD. , Korean pharmaceutical company -LRB- `` AJU '' -RRB- , for RBM-007 licensing agreement for the indication of the exudative age-related macular degeneration in the territory of Korea and Southeast Asia -LRB- Singapore , Philippines , Thailand , Vietnam , Indonesia , Malaysia , Cambodia and Myanmar ; hereinafter `` the Territory '' -RRB- .

Sources

4

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.